Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Struct Biol. 1994 Nov;1(11):795-801.Links

Trifluoperazine-induced conformational change in Ca(2+)-calmodulin.

Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.

Here we show that, as a consequence of binding the drug trifluoperazine, a major conformational movement occurs in Ca(2+)-calmodulin (CaM). The tertiary structure changes from an elongated dumb-bell, with exposed hydrophobic surfaces, to a compact globular form which can no longer interact with its target enzymes. It is likely that inactivation of Ca(2+)-CaM by trifluoperazine is due to this major tertiary-structural alteration in Ca(2+)-CaM, which is initiated and stabilized by drug binding. This conformational change is similar to that which occurs on the binding of Ca(2+)-CaM to target peptides. Two hydrophobic binding pockets, created by amino acid residues adjacent to Ca(2+)-coordinating residues, form the key recognition sites on Ca(2+)-CaM for both inhibitors and target enzymes.

PMID: 7634090 [PubMed - indexed for MEDLINE]

Structures reported by this article

Patient Drug Information

  • Trifluoperazine

    Trifluoperazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Trifluoperazine is also used on...